IT
Immunomet Therapeutics, Inc.
SEC filingBiotechnology · Houston, TX
Amount raised$842Ksold at filing
Total offering$10M$9.2M still open
Investors in the raise4count reported to the SEC
FiledFeb 5, 2026first sale Jan 21, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Dean WelschExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.